These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30717355)

  • 1. Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls.
    Marin-Alejandre BA; Abete I; Cantero I; Riezu-Boj JI; Milagro FI; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martínez JA; Zulet MA
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30717355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses.
    Kim CW; Yun KE; Jung HS; Chang Y; Choi ES; Kwon MJ; Lee EH; Woo EJ; Kim NH; Shin H; Ryu S
    J Hepatol; 2013 Aug; 59(2):351-7. PubMed ID: 23578884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.
    Bernsmeier C; Weisskopf DM; Pflueger MO; Mosimann J; Campana B; Terracciano L; Beglinger C; Heim MH; Cajochen C
    PLoS One; 2015; 10(11):e0143293. PubMed ID: 26576055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of sleep duration and sleep quality with non-alcoholic fatty liver disease in a Taiwanese population.
    Chou YT; Cheng HJ; Wu JS; Yang YC; Chou CY; Chang CJ; Lu FH
    Obes Res Clin Pract; 2018; 12(6):500-505. PubMed ID: 29929928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U; Yesil A; Yilmaz Y
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study.
    Recaredo G; Marin-Alejandre BA; Cantero I; Monreal JI; Herrero JI; Benito-Boillos A; Elorz M; Tur JA; Martínez JA; Zulet MA; Abete I
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31623368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of leptin and leptin resistance in non-alcoholic fatty liver disease development in persons with obesity and overweight].
    Livzan MA; Lapteva IV; Miller TS
    Eksp Klin Gastroenterol; 2014; (8):27-33. PubMed ID: 25911909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India.
    Bhatt SP; Guleria R; Vikram NK; Vivekanandhan S; Singh Y; Gupta AK
    PLoS One; 2018; 13(7):e0199599. PubMed ID: 30001365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
    Sookoian S; Pirola CJ
    Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
    Kimura T; Deshpande GA; Urayama KY; Masuda K; Fukui T; Matsuyama Y
    J Gastroenterol Hepatol; 2015 May; 30(5):909-17. PubMed ID: 25469977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease.
    Dai YN; Zhu JZ; Fang ZY; Zhao DJ; Wan XY; Zhu HT; Yu CH; Li YM
    Metabolism; 2015 Dec; 64(12):1667-73. PubMed ID: 26476959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Nonalcoholic Fatty Liver Disease on Renal Function in Children with Overweight/Obesity.
    Pacifico L; Bonci E; Andreoli GM; Di Martino M; Gallozzi A; De Luca E; Chiesa C
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27472326
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Sakamoto Y; Oniki K; Kumagae N; Morita K; Otake K; Ogata Y; Saruwatari J
    Dis Markers; 2019; 2019():4065327. PubMed ID: 31929840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
    Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
    Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.